Mink Therapeutics company info

What does Mink Therapeutics do?
Mink Therapeutics (NASDAQ:INKT) specializes in developing innovative therapies aimed at transforming the treatment landscape for patients facing serious diseases. With a focus on utilizing cutting-edge research and technology, Mink is dedicated to advancing a diverse portfolio of therapeutic candidates through clinical development. Their projects span a range of therapeutic areas, including oncology, autoimmune disorders, and infectious diseases. Mink's objective is to bring novel treatments from the bench to the bedside, addressing unmet medical needs and improving patient outcomes. The company's operations are fueled by a commitment to excellence in research and development, with an emphasis on collaboration and innovation to achieve breakthroughs in medicine.
Mink Therapeutics company media
Company Snapshot

Is Mink Therapeutics a public or private company?

key
Ownership
Public

How many people does Mink Therapeutics employ?

people
Employees
31

What sector is Mink Therapeutics in?

pie chart
Sector
Health Care

Where is the head office for Mink Therapeutics?

location pin
Head Office
New York, United States

What year was Mink Therapeutics founded?

founded flag
Year Founded
2017
What does Mink Therapeutics specialise in?
/Regenerative Therapies /Stem Cell Research /Skin Regeneration /Healthcare Innovations /Therapeutic Development /Clinical Trial Projects

What are the products and/or services of Mink Therapeutics?

Overview of Mink Therapeutics offerings
Development of novel immunotherapies targeting hard-to-treat cancers using proprietary technology.
Collaboration on a gene editing platform to enhance the efficacy of cancer treatments.
Research into personalized cancer vaccines leveraging patient-specific tumor neoantigens.
Advanced diagnostics services for early detection of oncological diseases.
Partnership in creating monoclonal antibodies for immune system modulation in cancer therapy.
Investment in AI-driven platforms for optimizing drug development processes.

Who is in the executive team of Mink Therapeutics?

Mink Therapeutics leadership team
  • Dr. Garo H. Armen Ph.D.
    Dr. Garo H. Armen Ph.D.
    Executive Chairman
  • Dr. Jennifer S. Buell Ph.D.
    Dr. Jennifer S. Buell Ph.D.
    President, CEO & Director
  • Dr. Marcus Antonius van Dijk Ph.D.
    Dr. Marcus Antonius van Dijk Ph.D.
    Chief Scientific Officer
  • Ms. Christine M. Klaskin
    Ms. Christine M. Klaskin
    Treasurer
  • Joy  Zhou Ph.D.
    Joy Zhou Ph.D.
    Vice President & Head of CMC